Eieling Technology Limited (Eieling Technology), co-founded by Prof. ZHENG Yongping, Director of the Research Institute of Smart Ageing (RISA) and his research team, has announced that it will implement the five-year “LiverCare – Hong Kong 10 Million Liver Scans Program”, with the goal to raise public awareness of liver disease prevention and promote early detection and treatment.
In addition, starting from July this year, PolyU will conduct liver fibrosis and fatty liver screening for full-time university staff using Liverscan®, a palm-size wireless ultrasound imaging device, and encourage participants to join a two-year follow-up study. From the data collected, the research team will study the importance of balanced diet, daily exercise and regular liver disease screening for monitoring the progression of liver disease.
Liverscan® has obtained registration clearance from the US Food and Drug Administration (FDA510K) and is being used in many well-known hospitals and clinics in Hong Kong, Macau and other places. Eieling Technology is also carrying out clinical research and cooperation with several hospitals in Mainland China. Liverscan® is expected to enter the market in Mainland China after receiving registration approval from the National Medical Products Administration in Q3 this year, and to be launched globally in 2025.
Press release: https://polyu.hk/qjpFI
Mirage - https://polyu.me/4anrrLu
Hong Kong China News Agency - https://polyu.me/3QQKlU5
| Research Units | Research Institute for Smart Ageing |
|---|
